APO Research
Talk to an analyst

APO RESEARCH · REPORT

Foot and Mouth Disease (FMD) Vaccines

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Selected research

Market Analysis & Forecast

Global Foot and Mouth Disease (FMD) Vaccines Market Analysis and Forecast 2026-2032

21 December 2025212 pages

Choose your research edition.

Industry ResearchFoot and Mouth Disease (FMD) Vaccines Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Foot and Mouth Disease (FMD) Vaccines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Foot and Mouth Disease (FMD) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Foot and Mouth Disease (FMD) Vaccines Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Foot and Mouth Disease (FMD) Vaccines Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.

Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.

Read the full market overview

In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.

This report presents an overview of global market for Foot and Mouth Disease (FMD) Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Foot and Mouth Disease (FMD) Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Foot and Mouth Disease (FMD) Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Foot and Mouth Disease (FMD) Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Foot and Mouth Disease (FMD) Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Foot and Mouth Disease (FMD) Vaccines sales, projected growth trends, production technology, application and end-user industry.

Foot and Mouth Disease (FMD) Vaccines Segment by Company

Jinyu Group

Cavet Bio

Indian Immunologicals

Tecon Group

CAHIC

Shen Lian

Biogenesis Bagó

BIGVET Biotech

Boehringer Ingelheim

MSD Animal Health

CEVA

FGBI

Bayer HealthCare

Brilliant Bio Pharma

VECOL

Sanofi (Merial)

VETAL

BVI

LIMOR

ME VAC

Agrovet

Foot and Mouth Disease (FMD) Vaccines Segment by Type

Emergency Vaccines

Conventional Vaccines

Foot and Mouth Disease (FMD) Vaccines Segment by Application

Cattle

Pig

Sheep and Goat

Others

Foot and Mouth Disease (FMD) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Foot and Mouth Disease (FMD) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Foot and Mouth Disease (FMD) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Foot and Mouth Disease (FMD) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Foot and Mouth Disease (FMD) Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Foot and Mouth Disease (FMD) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Foot and Mouth Disease (FMD) Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Emergency Vaccines Major Manufacturers Table 3. Conventional Vaccines Major Manufacturers Table 4. Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cattle Major Manufacturers Table 6. Pig Major Manufacturers Table 7. Sheep and Goat Major Manufacturers Table 8. Others Major Manufacturers Table 9. Foot and Mouth Disease (FMD) Vaccines Industry Trends Table 10. Foot and Mouth Disease (FMD) Vaccines Industry Drivers Table 11. Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges Table 12. Foot and Mouth Disease (FMD) Vaccines Industry Restraints Table 13. Global Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2021-2026) Table 17. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2027-2032) Table 18. Global Foot and Mouth Disease (FMD) Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Doses) Table 19. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2021-2026) & (M Doses) Table 20. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2027-2032) & (M Doses) Table 21. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2021-2026) Table 22. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2027-2032) Table 23. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Manufacturers (2021-2026) Table 27. Global Foot and Mouth Disease (FMD) Vaccines Sales Price (USD/K Doses) of Manufacturers (2021-2026) Table 28. Global Foot and Mouth Disease (FMD) Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Foot and Mouth Disease (FMD) Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Foot and Mouth Disease (FMD) Vaccines Manufacturers, Product Type & Application Table 31. Global Foot and Mouth Disease (FMD) Vaccines Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Foot and Mouth Disease (FMD) Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2021-2026) Table 38. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2027-2032) Table 39. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 40. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 41. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2027-2032) & (M Doses) Table 42. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2021-2026) Table 43. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2027-2032) Table 44. Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2021-2026) & (USD/K Doses) Table 45. Global Foot and Mouth Disease (FMD) Vaccines Price by Type (2027-2032) & (USD/K Doses) Table 46. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2021-2026) Table 50. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2027-2032) Table 51. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 52. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 53. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2027-2032) & (M Doses) Table 54. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2021-2026) Table 55. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2027-2032) Table 56. Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2021-2026) & (USD/K Doses) Table 57. Global Foot and Mouth Disease (FMD) Vaccines Price by Application (2027-2032) & (USD/K Doses) Table 58. Jinyu Group Company Information Table 59. Jinyu Group Business Overview Table 60. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 61. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 62. Jinyu Group Recent Development Table 63. Cavet Bio Company Information Table 64. Cavet Bio Business Overview Table 65. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 66. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 67. Cavet Bio Recent Development Table 68. Indian Immunologicals Company Information Table 69. Indian Immunologicals Business Overview Table 70. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 71. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 72. Indian Immunologicals Recent Development Table 73. Tecon Group Company Information Table 74. Tecon Group Business Overview Table 75. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 76. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 77. Tecon Group Recent Development Table 78. CAHIC Company Information Table 79. CAHIC Business Overview Table 80. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 81. CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 82. CAHIC Recent Development Table 83. Shen Lian Company Information Table 84. Shen Lian Business Overview Table 85. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 86. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 87. Shen Lian Recent Development Table 88. Biogenesis Bagó Company Information Table 89. Biogenesis Bagó Business Overview Table 90. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 91. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 92. Biogenesis Bagó Recent Development Table 93. BIGVET Biotech Company Information Table 94. BIGVET Biotech Business Overview Table 95. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 96. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 97. BIGVET Biotech Recent Development Table 98. Boehringer Ingelheim Company Information Table 99. Boehringer Ingelheim Business Overview Table 100. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 101. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 102. Boehringer Ingelheim Recent Development Table 103. MSD Animal Health Company Information Table 104. MSD Animal Health Business Overview Table 105. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 106. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 107. MSD Animal Health Recent Development Table 108. CEVA Company Information Table 109. CEVA Business Overview Table 110. CEVA Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 111. CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 112. CEVA Recent Development Table 113. FGBI Company Information Table 114. FGBI Business Overview Table 115. FGBI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 116. FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 117. FGBI Recent Development Table 118. Bayer HealthCare Company Information Table 119. Bayer HealthCare Business Overview Table 120. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 121. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 122. Bayer HealthCare Recent Development Table 123. Brilliant Bio Pharma Company Information Table 124. Brilliant Bio Pharma Business Overview Table 125. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 126. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 127. Brilliant Bio Pharma Recent Development Table 128. VECOL Company Information Table 129. VECOL Business Overview Table 130. VECOL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 131. VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 132. VECOL Recent Development Table 133. Sanofi (Merial) Company Information Table 134. Sanofi (Merial) Business Overview Table 135. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 136. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 137. Sanofi (Merial) Recent Development Table 138. VETAL Company Information Table 139. VETAL Business Overview Table 140. VETAL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 141. VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 142. VETAL Recent Development Table 143. BVI Company Information Table 144. BVI Business Overview Table 145. BVI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 146. BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 147. BVI Recent Development Table 148. LIMOR Company Information Table 149. LIMOR Business Overview Table 150. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 151. LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 152. LIMOR Recent Development Table 153. ME VAC Company Information Table 154. ME VAC Business Overview Table 155. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 156. ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 157. ME VAC Recent Development Table 158. Agrovet Company Information Table 159. Agrovet Business Overview Table 160. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 161. Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 162. Agrovet Recent Development Table 163. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 164. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 165. North America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 166. North America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2027-2032) & (M Doses) Table 167. North America Foot and Mouth Disease (FMD) Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 168. North America Foot and Mouth Disease (FMD) Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 169. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 170. North America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 171. North America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 172. North America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2027-2032) & (M Doses) Table 173. North America Foot and Mouth Disease (FMD) Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 174. North America Foot and Mouth Disease (FMD) Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 175. North America Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. North America Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. North America Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 179. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 180. North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 181. North America Foot and Mouth Disease (FMD) Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 182. North America Foot and Mouth Disease (FMD) Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 183. United States Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 184. Canada Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 185. Mexico Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 186. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 187. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 188. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 189. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2027-2032) & (M Doses) Table 190. Europe Foot and Mouth Disease (FMD) Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 191. Europe Foot and Mouth Disease (FMD) Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 192. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 193. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 194. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 195. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application (2027-2032) & (M Doses) Table 196. Europe Foot and Mouth Disease (FMD) Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 197. Europe Foot and Mouth Disease (FMD) Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 198. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 200. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 201. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 202. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 203. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 204. Europe Foot and Mouth Disease (FMD) Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 205. Europe Foot and Mouth Disease (FMD) Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 206. Germany Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 207. France Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 208. U.K. Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 209. Italy Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 210. Russia Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 211. Spain Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 212. Netherlands Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 213. Switzerland Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 214. Sweden Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 215. Poland Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 216. China Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 217. China Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 218. China Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 219. China Foot and Mouth Disease (FMD) Vaccines Sales by Type (2027-2032) & (M Doses) Table 220. China Foot and Mouth Disease (FMD) Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 221. China Foot and Mouth Disease (FMD) Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 222. China Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 223. China Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 224. China Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 225. China Foot and Mouth Disease (FMD) Vaccines Sales by Application (2027-2032) & (M Doses) Table 226. China Foot and Mouth Disease (FMD) Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 227. China Foot and Mouth Disease (FMD) Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 228. Asia Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 229. Asia Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 230. Asia Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 231. Asia Foot and Mouth Disease (FMD) Vaccines Sales by Type (2027-2032) & (M Doses) Table 232. Asia Foot and Mouth Disease (FMD) Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 233. Asia Foot and Mouth Disease (FMD) Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 234. Asia Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 235. Asia Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 236. Asia Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 237. Asia Foot and Mouth Disease (FMD) Vaccines Sales by Application (2027-2032) & (M Doses) Table 238. Asia Foot and Mouth Disease (FMD) Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 239. Asia Foot and Mouth Disease (FMD) Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 240. Asia Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 241. Asia Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 242. Asia Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 243. Asia Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 244. Asia Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 245. Asia Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 246. Asia Foot and Mouth Disease (FMD) Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 247. Asia Foot and Mouth Disease (FMD) Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 248. Japan Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 249. South Korea Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 250. India Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 251. Australia Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 252. Taiwan Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 253. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 254. SAMEA Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 255. SAMEA Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 256. SAMEA Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2026) & (M Doses) Table 257. SAMEA Foot and Mouth Disease (FMD) Vaccines Sales by Type (2027-2032) & (M Doses) Table 258. SAMEA Foot and Mouth Disease (FMD) Vaccines Sales Price by Type (2021-2026) & (USD/K Doses) Table 259. SAMEA Foot and Mouth Disease (FMD) Vaccines Sales Price by Type (2027-2032) & (USD/K Doses) Table 260. SAMEA Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 261. SAMEA Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 262. SAMEA Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2026) & (M Doses) Table 263. SAMEA Foot and Mouth Disease (FMD) Vaccines Sales by Application (2027-2032) & (M Doses) Table 264. SAMEA Foot and Mouth Disease (FMD) Vaccines Sales Price by Application (2021-2026) & (USD/K Doses) Table 265. SAMEA Foot and Mouth Disease (FMD) Vaccines Sales Price by Application (2027-2032) & (USD/K Doses) Table 266. SAMEA Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 267. SAMEA Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 268. SAMEA Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 269. SAMEA Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Doses) Table 270. SAMEA Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 271. SAMEA Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 272. SAMEA Foot and Mouth Disease (FMD) Vaccines Sales Price by Country (2021-2026) & (USD/K Doses) Table 273. SAMEA Foot and Mouth Disease (FMD) Vaccines Sales Price by Country (2027-2032) & (USD/K Doses) Table 274. Brazil Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 275. Argentina Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 276. Chile Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 277. Colombia Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 278. Peru Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 279. Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 280. Israel Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 281. UAE Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 282. Turkey Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 283. Iran Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 284. Egypt Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Table 285. Key Raw Materials Table 286. Raw Materials Key Suppliers Table 287. Foot and Mouth Disease (FMD) Vaccines Distributors List Table 288. Foot and Mouth Disease (FMD) Vaccines Customers List Table 289. Research Programs/Design for This Report Table 290. Authors List of This Report Table 291. Secondary Sources Table 292. Primary Sources List of Figures Figure 1. Foot and Mouth Disease (FMD) Vaccines Image Figure 2. Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Foot and Mouth Disease (FMD) Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Emergency Vaccines Image Figure 5. Conventional Vaccines Image Figure 6. Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Foot and Mouth Disease (FMD) Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cattle Image Figure 9. Pig Image Figure 10. Sheep and Goat Image Figure 11. Others Image Figure 12. Global Foot and Mouth Disease (FMD) Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Foot and Mouth Disease (FMD) Vaccines Revenue (2021-2032) & (US$ Million) Figure 14. Global Foot and Mouth Disease (FMD) Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2021-2032) Figure 17. Global Foot and Mouth Disease (FMD) Vaccines Sales (2021-2032) & (M Doses) Figure 18. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 19. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Foot and Mouth Disease (FMD) Vaccines Sales YoY (2021-2032) & (M Doses) Figure 21. Europe Foot and Mouth Disease (FMD) Vaccines Sales YoY (2021-2032) & (M Doses) Figure 22. China Foot and Mouth Disease (FMD) Vaccines Sales YoY (2021-2032) & (M Doses) Figure 23. Asia (Excluding China) Foot and Mouth Disease (FMD) Vaccines Sales YoY (2021-2032) & (M Doses) Figure 24. South America, Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales YoY (2021-2032) & (M Doses) Figure 25. Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2021-2032) Figure 31. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 32. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2021-2032) Figure 34. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2021-2032) Figure 37. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 38. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2021-2032) Figure 40. North America Foot and Mouth Disease (FMD) Vaccines Revenue Share by Type (2021-2032) Figure 41. North America Foot and Mouth Disease (FMD) Vaccines Sales Share by Type (2021-2032) Figure 42. North America Foot and Mouth Disease (FMD) Vaccines Revenue Share by Application (2021-2032) Figure 43. North America Foot and Mouth Disease (FMD) Vaccines Sales Share by Application (2021-2032) Figure 44. North America Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country (2021-2032) Figure 45. North America Foot and Mouth Disease (FMD) Vaccines Sales Share by Country (2021-2032) Figure 46. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Share by Type (2021-2032) Figure 47. Europe Foot and Mouth Disease (FMD) Vaccines Sales Share by Type (2021-2032) Figure 48. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Share by Application (2021-2032) Figure 49. Europe Foot and Mouth Disease (FMD) Vaccines Sales Share by Application (2021-2032) Figure 50. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Share by Country (2021-2032) Figure 51. Europe Foot and Mouth Disease (FMD) Vaccines Sales Share by Country (2021-2032) Figure 52. China Foot and Mouth Disease (FMD) Vaccines Revenue Share by Type (2021-2032) Figure 53. China Foot and Mouth Disease (FMD) Vaccines Sales Share by Type (2021-2032) Figure 54. China Foot and Mouth Disease (FMD) Vaccines Revenue Share by Application (2021-2032) Figure 55. China Foot and Mouth Disease (FMD) Vaccines Sales Share by Application (2021-2032) Figure 56. Asia Foot and Mouth Disease (FMD) Vaccines Revenue Share by Type (2021-2032) Figure 57. Asia Foot and Mouth Disease (FMD) Vaccines Sales Share by Type (2021-2032) Figure 58. Asia Foot and Mouth Disease (FMD) Vaccines Revenue Share by Application (2021-2032) Figure 59. Asia Foot and Mouth Disease (FMD) Vaccines Sales Share by Application

Scope & coverage.

Types
  • Emergency Vaccines
  • Conventional Vaccines
Applications
  • Cattle
  • Pig
  • Sheep and Goat
  • Others
Companies covered
  • Jinyu Group
  • Cavet Bio
  • Indian Immunologicals
  • Tecon Group
  • CAHIC
  • Shen Lian
  • Biogenesis Bagó
  • BIGVET Biotech
  • Boehringer Ingelheim
  • MSD Animal Health
  • CEVA
  • FGBI
  • Bayer HealthCare
  • Brilliant Bio Pharma
  • VECOL
  • Sanofi (Merial)
  • VETAL
  • BVI
  • LIMOR
  • ME VAC
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Foot and Mouth Disease (FMD) Vaccines Market by Type
  3. 1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Emergency Vaccines
  5. 1.2.3 Conventional Vaccines
  6. 1.3 Foot and Mouth Disease (FMD) Vaccines Market by Application
  7. 1.3.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cattle
  9. 1.3.3 Pig
  10. 1.3.4 Sheep and Goat
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Foot and Mouth Disease (FMD) Vaccines Market Dynamics
  1. 2.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends
  2. 2.2 Foot and Mouth Disease (FMD) Vaccines Industry Drivers
  3. 2.3 Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges
  4. 2.4 Foot and Mouth Disease (FMD) Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region
  3. 3.2.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region
  9. 3.4.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers
  6. 4.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Foot and Mouth Disease (FMD) Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Foot and Mouth Disease (FMD) Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Foot and Mouth Disease (FMD) Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Foot and Mouth Disease (FMD) Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Foot and Mouth Disease (FMD) Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Foot and Mouth Disease (FMD) Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Foot and Mouth Disease (FMD) Vaccines Tier 1, Tier 2, and Tier 3
5 Foot and Mouth Disease (FMD) Vaccines Market by Type
  1. 5.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type
  2. 5.1.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type
  6. 5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2032) & (M Doses)
  8. 5.2.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Type
6 Foot and Mouth Disease (FMD) Vaccines Market by Application
  1. 6.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application
  2. 6.1.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application
  6. 6.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2032) & (M Doses)
  8. 6.2.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Foot and Mouth Disease (FMD) Vaccines Price by Application
7 Company Profiles
  1. 7.1 Jinyu Group
  2. 7.1.1 Jinyu Group Company Information
  3. 7.1.2 Jinyu Group Business Overview
  4. 7.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  6. 7.1.5 Jinyu Group Recent Developments
  7. 7.2 Cavet Bio
  8. 7.2.1 Cavet Bio Company Information
  9. 7.2.2 Cavet Bio Business Overview
  10. 7.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  12. 7.2.5 Cavet Bio Recent Developments
  13. 7.3 Indian Immunologicals
  14. 7.3.1 Indian Immunologicals Company Information
  15. 7.3.2 Indian Immunologicals Business Overview
  16. 7.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  18. 7.3.5 Indian Immunologicals Recent Developments
  19. 7.4 Tecon Group
  20. 7.4.1 Tecon Group Company Information
  21. 7.4.2 Tecon Group Business Overview
  22. 7.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  24. 7.4.5 Tecon Group Recent Developments
  25. 7.5 CAHIC
  26. 7.5.1 CAHIC Company Information
  27. 7.5.2 CAHIC Business Overview
  28. 7.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  30. 7.5.5 CAHIC Recent Developments
  31. 7.6 Shen Lian
  32. 7.6.1 Shen Lian Company Information
  33. 7.6.2 Shen Lian Business Overview
  34. 7.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  36. 7.6.5 Shen Lian Recent Developments
  37. 7.7 Biogenesis Bagó
  38. 7.7.1 Biogenesis Bagó Company Information
  39. 7.7.2 Biogenesis Bagó Business Overview
  40. 7.7.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  42. 7.7.5 Biogenesis Bagó Recent Developments
  43. 7.8 BIGVET Biotech
  44. 7.8.1 BIGVET Biotech Company Information
  45. 7.8.2 BIGVET Biotech Business Overview
  46. 7.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  48. 7.8.5 BIGVET Biotech Recent Developments
  49. 7.9 Boehringer Ingelheim
  50. 7.9.1 Boehringer Ingelheim Company Information
  51. 7.9.2 Boehringer Ingelheim Business Overview
  52. 7.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  54. 7.9.5 Boehringer Ingelheim Recent Developments
  55. 7.10 MSD Animal Health
  56. 7.10.1 MSD Animal Health Company Information
  57. 7.10.2 MSD Animal Health Business Overview
  58. 7.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  60. 7.10.5 MSD Animal Health Recent Developments
  61. 7.11 CEVA
  62. 7.11.1 CEVA Company Information
  63. 7.11.2 CEVA Business Overview
  64. 7.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  66. 7.11.5 CEVA Recent Developments
  67. 7.12 FGBI
  68. 7.12.1 FGBI Company Information
  69. 7.12.2 FGBI Business Overview
  70. 7.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  72. 7.12.5 FGBI Recent Developments
  73. 7.13 Bayer HealthCare
  74. 7.13.1 Bayer HealthCare Company Information
  75. 7.13.2 Bayer HealthCare Business Overview
  76. 7.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  78. 7.13.5 Bayer HealthCare Recent Developments
  79. 7.14 Brilliant Bio Pharma
  80. 7.14.1 Brilliant Bio Pharma Company Information
  81. 7.14.2 Brilliant Bio Pharma Business Overview
  82. 7.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  84. 7.14.5 Brilliant Bio Pharma Recent Developments
  85. 7.15 VECOL
  86. 7.15.1 VECOL Company Information
  87. 7.15.2 VECOL Business Overview
  88. 7.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  90. 7.15.5 VECOL Recent Developments
  91. 7.16 Sanofi (Merial)
  92. 7.16.1 Sanofi (Merial) Company Information
  93. 7.16.2 Sanofi (Merial) Business Overview
  94. 7.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  96. 7.16.5 Sanofi (Merial) Recent Developments
  97. 7.17 VETAL
  98. 7.17.1 VETAL Company Information
  99. 7.17.2 VETAL Business Overview
  100. 7.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  102. 7.17.5 VETAL Recent Developments
  103. 7.18 BVI
  104. 7.18.1 BVI Company Information
  105. 7.18.2 BVI Business Overview
  106. 7.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  108. 7.18.5 BVI Recent Developments
  109. 7.19 LIMOR
  110. 7.19.1 LIMOR Company Information
  111. 7.19.2 LIMOR Business Overview
  112. 7.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  114. 7.19.5 LIMOR Recent Developments
  115. 7.20 ME VAC
  116. 7.20.1 ME VAC Company Information
  117. 7.20.2 ME VAC Business Overview
  118. 7.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  120. 7.20.5 ME VAC Recent Developments
  121. 7.21 Agrovet
  122. 7.21.1 Agrovet Company Information
  123. 7.21.2 Agrovet Business Overview
  124. 7.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  126. 7.21.5 Agrovet Recent Developments
8 North America
  1. 8.1 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Type
  2. 8.1.1 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Foot and Mouth Disease (FMD) Vaccines Price by Type (2021-2032)
  5. 8.2 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Application
  6. 8.2.1 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Foot and Mouth Disease (FMD) Vaccines Price by Application (2021-2032)
  9. 8.3 North America Foot and Mouth Disease (FMD) Vaccines Market Size by Country
  10. 8.3.1 North America Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Foot and Mouth Disease (FMD) Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Type
  2. 9.1.1 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Foot and Mouth Disease (FMD) Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Application
  6. 9.2.1 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Foot and Mouth Disease (FMD) Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Foot and Mouth Disease (FMD) Vaccines Market Size by Country
  10. 9.3.1 Europe Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Foot and Mouth Disease (FMD) Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Foot and Mouth Disease (FMD) Vaccines Market Size by Type
  2. 10.1.1 China Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Foot and Mouth Disease (FMD) Vaccines Price by Type (2021-2032)
  5. 10.2 China Foot and Mouth Disease (FMD) Vaccines Market Size by Application
  6. 10.2.1 China Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Foot and Mouth Disease (FMD) Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Foot and Mouth Disease (FMD) Vaccines Market Size by Type
  2. 11.1.1 Asia Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Foot and Mouth Disease (FMD) Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Foot and Mouth Disease (FMD) Vaccines Market Size by Application
  6. 11.2.1 Asia Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Foot and Mouth Disease (FMD) Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Foot and Mouth Disease (FMD) Vaccines Market Size by Country
  10. 11.3.1 Asia Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Foot and Mouth Disease (FMD) Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Foot and Mouth Disease (FMD) Vaccines Market Size by Type
  2. 12.1.1 SAMEA Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Foot and Mouth Disease (FMD) Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Foot and Mouth Disease (FMD) Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Foot and Mouth Disease (FMD) Vaccines Market Size by Application
  6. 12.2.1 SAMEA Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Foot and Mouth Disease (FMD) Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Foot and Mouth Disease (FMD) Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Foot and Mouth Disease (FMD) Vaccines Market Size by Country
  10. 12.3.1 SAMEA Foot and Mouth Disease (FMD) Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Foot and Mouth Disease (FMD) Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Foot and Mouth Disease (FMD) Vaccines Value Chain Analysis
  2. 13.1.1 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Foot and Mouth Disease (FMD) Vaccines Production Mode & Process
  6. 13.2 Foot and Mouth Disease (FMD) Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Foot and Mouth Disease (FMD) Vaccines Distributors
  9. 13.2.3 Foot and Mouth Disease (FMD) Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst